Results
40
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
40 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
FTHM | US$1.84 | -4.2% | -40.1% | US$38.7m | US$4.44 | PS0.1x | E37.8% | n/a | ||
EXPI | US$12.83 | -7.8% | 3.0% | US$2.0b | US$15.75 | PS0.4x | E124.0% | 1.6% | ||
KANP | US$42.00 | 0% | n/a | US$77.5m | n/a | PE108.2x | n/a | n/a | ||
AEI | US$1.07 | -6.1% | -10.1% | US$9.9m | n/a | PS0.7x | n/a | n/a | ||
ZG | US$72.55 | 0.5% | 89.6% | US$17.4b | US$71.06 | PS7.9x | E68.7% | n/a | ||
AXR | US$36.58 | 7.7% | 117.1% | US$192.3m | n/a | PE20.4x | n/a | n/a | ||
STLY | US$5.14 | -8.3% | -14.2% | US$14.5m | n/a | PS1.3x | n/a | n/a | ||
CKX | US$12.93 | 1.0% | 4.1% | US$26.2m | n/a | PE57x | n/a | 0% | ||
BEKE | US$20.63 | 3.3% | 31.4% | US$24.8b | US$23.85 | PE43.2x | E19.9% | 1.6% | ||
CHCI | US$9.36 | 3.5% | 115.2% | US$92.6m | n/a | PE15.2x | n/a | n/a | ||
TUXS | US$2.10 | 0% | n/a | US$2.6m | n/a | PB0.4x | n/a | n/a | ||
MMI | US$40.64 | -1.3% | 23.8% | US$1.6b | US$30.00 | PS2.5x | E123.0% | 1.2% | ||
REAX | US$4.96 | -5.7% | 254.3% | US$979.9m | US$7.50 | PS0.9x | E51.7% | n/a | ||
MDJH | US$0.19 | -0.6% | -87.4% | US$2.9m | n/a | PS25.3x | n/a | n/a | ||
AWCA | US$0.69 | -1.4% | 102.3% | US$264.2m | n/a | PS5212.8x | n/a | n/a | ||
CPTP | US$9.89 | -0.9% | -16.9% | US$65.3m | n/a | PE27.5x | n/a | 2.8% | ||
RMR | US$21.88 | -4.0% | -7.3% | US$696.8m | US$27.50 | PE16.2x | E4.7% | 8.2% | ||
SRRE | US$0.25 | 0% | -13.2% | US$17.2m | n/a | PS0.9x | n/a | 0% | ||
CDJM | US$0.063 | 0% | n/a | US$3.2m | n/a | PE62x | n/a | n/a | ||
FPH | US$3.85 | 2.7% | 49.2% | US$572.2m | n/a | PE5.2x | n/a | n/a | ||
CSGP | US$72.09 | -4.9% | -14.0% | US$29.6b | US$90.08 | PE168.5x | E42.5% | n/a | ||
CPPT.L | US$11.40 | 1.3% | 11.5% | US$855.0m | n/a | PE12.7x | n/a | 14.7% | ||
AOXY | US$0.064 | 0% | -57.9% | US$210.7k | n/a | PE50.2x | n/a | n/a | ||
BRRE | US$8.45 | 0% | n/a | US$20.4m | n/a | PS3.1x | n/a | n/a |